Table 5.
Intervention/Therapy | Mechanism of Action |
---|---|
Hypothermia [81,82,83,84] | Reduces metabolic rate, potentially decreasing secondary injury by lowering body temperature |
GM-1 + mNGF [79] | Reduce excitatory neurotransmitters, Na+-K+-ATPase and Ca2+-ATPase activity, inflammation, oxidative stress, calcium buildup, and apoptosis; promote nerve growth and membrane repair |
BA-210 [72] | Inhibits the Rho pathway, which is involved in growth-inhibitory proteins after CNS injury, promoting recovery |
Riluzole [86] | Blocks voltage-sensitive sodium channels and inhibits presynaptic calcium-dependent glutamate release, providing neuroprotective effects |
Immune Therapy Targets [80] | Target transmembrane proteins on immature dendritic cells, preventing their maturation, which may aid in SCI recovery |
Minocycline [78] | Acts as an antibiotic with anti-apoptotic properties, potentially reducing cell death post-SCI |
GM-1: Ganglioside Monosialotetrahexosylganglioside; mNGF: mouse Nerve Growth Factor.